HAMBURG, Germany, April 29, 2021 (GLOBE NEWSWIRE) — We are advised by GSB GOLD STANDARD BANKING CORPORATION AG that journalists and other readers should disregard the news release, "GSB Group doubts in gold reserves of Karatbars and the V999 Coin as well as the existence of the Osint Group" issued April 28, 2021, over GlobeNewswire.
GLOBENEWSWIRE (Distribution ID 8225801)
LONDON and SYDNEY, Australia and JOHANNESBURG, South Africa, April 29, 2021 (GLOBE NEWSWIRE) — FXCM Group, LLC (“FXCM Group” or "FXCM"), a leading international provider of online foreign exchange trading, CFD trading and related services, today released execution data for March 2021. To view execution data including historical spreads, execution speeds and historical price improvement data click here: https://www.fxcm.com/uk/about–fxcm/execution–transparency/.
March 2021 All Instruments Highlights:*
Highlighted Instruments March 2021:
| Instrument | Active Trader Peak Spread5 |
Active Trader Non–Peak Spread5 |
Active Trader Effective Spread6 |
At Price Orders |
Positive Slippage |
Negative Slippage |
|||
| XAU/USD | 0.4 | 0.4 | 0.4 | 50.7 | % | 34.5 | % | 14.8 | % |
| SPX500 | 0.4 | 0.4 | 0.4 | 53.5 | % | 27.6 | % | 18.9 | % |
| NAS100 | 1.1 | 1.1 | 1.0 | 41.5 | % | 36.9 | % | 21.6 | % |
| EUR/USD | 0.1 | 0.4 | 0.2 | 71.4 | % | 19.7 | % | 8.9 | % |
| GBP/USD | 0.4 | 1.0 | 0.5 | 70.2 | % | 20.0 | % | 9.8 | % |
| AUD/USD | 0.2 | 0.5 | 0.2 | 73.8 | % | 18.3 | % | 7.9 | % |
For more information and to open a live account, traders can contact an FXCM specialist 24 hours a day, 5 days a week.
*These highlights come from orders that executed through FXCM Group from 1 March 2021, to 31 March 2021. Data excludes certain types of non–direct clients.
1Percentage of executed client trades# in March 2021, which were executed at the price clients requested.
2Percentage of executed client trades# in March 2021, which were executed at a more favorable price than the price clients requested.
3Percentage of executed client trades# in March 2021, which were executed at a less favorable price than the price clients requested.
4This defines the amount of time between when we receive the order until execution. This excludes internet latency and post trade booking.
5This data is compiled forex and CFD trading data from FXCM's Active Traders for 1 March 2021, to 31 March 2021. The data reflects average spreads made available to FXCM clients during all trading hours.
6This data is compiled forex and CFD trading data from FXCM's Active Traders for 1 March 2021, to 31 March 2021. The data reflects the spread at which trades were executed by FXCM clients during all trading hours.
#Client trades here cover stop, limit, "at market", and entry orders. Certain non–direct clients are excluded from the data. Limit and limit entry orders would only execute at the requested price or better and cannot receive negative slippage. Price improvements are subject to available liquidity.
About FXCM:
FXCM is a leading provider of online foreign exchange (FX) trading, CFD trading, and related services. Founded in 1999, the company's mission is to provide global traders with access to the world's largest and most liquid market by offering innovative trading tools, hiring excellent trading educators, meeting strict financial standards and striving for the best online trading experience in the market. Clients have the advantage of mobile trading, one–click order execution and trading from real–time charts. In addition, FXCM offers educational courses on FX trading and provides trading tools, proprietary data and premium resources. FXCM Pro provides retail brokers, small hedge funds and emerging market banks access to wholesale execution and liquidity, while providing high and medium frequency funds access to prime brokerage services via FXCM Prime. FXCM is a Leucadia Company.
Forex Capital Markets Limited: FCA registration number 217689 (www.fxcm.com/uk)
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76.31% of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
FXCM EU LTD: CySEC license number 392/20 (www.fxcm.com/eu)
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Between 74–89% of retail investor accounts lose money when trading CFDs.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
FXCM Australia Pty. Limited: AFSL 309763. Losses can exceed your deposited funds. The products may not be suitable for all investors. Please ensure that you fully understand the risks involved. If you decide to trade products offered by FXCM AU, you must read and understand the Financial Services Guide, Product Disclosure Statement, and Terms of Business on www.fxcm.com/au.
FXCM South Africa (PTY) Ltd: FSP No 46534 (www.fxcm.com/za). Our service includes products that are traded on margin and carry a risk of losses in excess of your deposited funds. The products may not be suitable for all investors. Please ensure that you fully understand the risks involved.
FXCM Markets Limited: Losses can exceed deposited funds. (www.fxcm.com/markets).
Media contact:
Chatsworth Communications
+44 (0) 20 7440 9780
fxcm@chatsworthcommunications.com
GLOBENEWSWIRE (Distribution ID 8226605)
London, United Kingdom & Geneva, Switzerland, April 29, 2021 (GLOBE NEWSWIRE) — SNOMED International and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) are announcing the release of important new maps between global medical terminologies SNOMED CT and MedDRA. This collaborative effort is the first deliverable of a new agreement entered into between SNOMED International and ICH.
ICH is an international non–profit organisation which brings together regulatory authorities and pharmaceutical industry from across the globe to discuss scientific and technical aspects of pharmaceuticals and to develop ICH guidelines. Owned by ICH, MedDRA, the Medical Dictionary for Regulatory Activities, is a rich and highly specific standardised medical terminology developed by ICH to facilitate sharing of regulatory information internationally for medical products used by humans and is used for registration, documentation and safety monitoring of medical products both before and after a product has been authorised for use. SNOMED International is the not–for–profit organization that owns and maintains SNOMED CT, the world's most comprehensive clinical terminology with over 350,000 concepts ranging across diagnosis, signs and symptoms and tens of thousands of surgical, therapeutic and diagnostic procedures.
This joint effort has produced two independent maps (MedDRA to SNOMED CT and SNOMED CT to MedDRA) which have been derived from frequently used and key pharmacovigilance MedDRA terms identified from the European Medicines Agency and the UK's Medicines & Healthcare products Regulatory Agency. In addition, a set of COVID–19 related terms are also included in the first production release of the maps to capture important aspects of the pandemic.
The maps are intended to facilitate the exchange of data between regulatory databases (which use MedDRA) and healthcare databases/electronic health records (which use SNOMED CT). In one use case, key pharmacovigilance concepts coded in SNOMED CT in an electronic health record (EHR) could be converted to MedDRA for the purpose of adverse event reporting to regulatory authorities or for the purposes of epidemiological research. In the opposite direction, these same key terms coded in MedDRA representing adverse events, warnings, and other regulatory information could be converted into SNOMED CT so that the information is available in the patient's record to aid in clinical decision–making.
The two maps were created as part of a project involving SNOMED International and ICH entitled WEB–RADR 2. Funded by the Innovative Medicines Initiative (IMI), a large–scale public–private partnership between the EU and the pharmaceutical industry association, EFPIA, IMI aims to boost biopharmaceutical innovation in Europe and to speed up the development of better and safer medicines for patients. With the creation of the maps from the WEB–RADR 2 project, both SNOMED International and ICH have committed to their ongoing use and maintenance extending past the conclusion of the project.
Mick Foy, Medicines and Healthcare products Regulatory Agency UK and Chair of the ICH MedDRA Management Committee said "This is an exciting development and an important milestone. Developing interoperability between SNOMED CT and MedDRA has been a long–standing ambition and will greatly enhance data collection for regulatory purposes and for drug safety research".
SNOMED International CEO, Don Sweete, welcomes the evolution of the organization's relationship with ICH. "It is exciting to see a long–term alliance borne from a collaborative project created to improve drug safety for patients and citizens. This agreement serves a joint commitment by two organizations dedicated to enabling health systems interoperability across regulatory and clinical continuums."
The Production version of the two maps is being made available to licensed SNOMED CT and MedDRA users on April 30, 2021 and will be based on the January 2021 version of SNOMED CT and the September 2020 version of MedDRA. It is planned that the maps will be released annually in April.
To access the maps:
Visit SNOMED International or MedDRA's Maintenance and Support Services Organization (MSSO) for map release documents, including:
For more information on these maps and resources, please contact MedDRA MSSO (mssohelp@meddra.org) or SNOMED International (info@snomed.org).
About SNOMED International:
SNOMED International is a not–for–profit organization that owns and develops SNOMED CT, the world's most comprehensive healthcare terminology product. We play an essential role in improving the health of humankind by determining standards for a codified language that represents groups of clinical terms. This enables healthcare information to be exchanged globally for the benefit of patients and other stakeholders. We are committed to the rigorous evolution of our products and services, to deliver continuous innovation for the global healthcare community. SNOMED International is the trading name of the International Health Terminology Standards Development Organisation.
To learn more about SNOMED International and SNOMED CT, visit www.snomed.org.
About the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is an international non–profit organisation unique in bringing together the regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of pharmaceuticals and develop ICH guidelines. ICH's mission is to achieve greater harmonisation worldwide to ensure that safe, effective and high quality medicines are developed, and registered and maintained in the most resource efficient manner whilst meeting high standards. MedDRA has been developed by ICH and is continuously enhanced to meet the evolving needs of regulators and industry around the world.
To learn more about the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and MedDRA, visit www.ich.org and www.meddra.org.
Attachment
GLOBENEWSWIRE (Distribution ID 8226548)
RENSSELAER, N.Y., April 29, 2021 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of a new COVID–19 mouse model. This human ACE2 (hACE2) transgenic mouse expands Taconic's COVID–19 research toolkit.
In October 2020, Taconic launched its first hACE2 model. The AC70 mouse experiences a lethal response to infection by SARS–CoV–2, the virus that causes COVID–19. Conversely, the new AC22 mouse is lethality–resistant, enabling therapeutic, vaccine, and post–infection symptom research.
Although various hACE2 mouse models of lethal SARS–CoV–2 infection exist, the hACE2 AC22 lethality–resistant model is important because it permits study of sublethal infection. Most humans infected with SARS–CoV–2 survive, and an animal model which replicates sublethal disease and recovery is needed. The hACE2 AC22 mouse provides a longer study window to assess drug efficacy compared to lethal infection models.
"While vaccines bring hope of an end to the pandemic, research on COVID–19 is still needed," shared Dr. Michael Seiler, vice president of commercial models at Taconic. "There is a huge population of people who have now had the disease. We need models that also survive this disease long enough to aid in replicating that human condition. It cannot be overstated just how important this new AC22 model is in enabling that research."
Study ready cohorts of animals are available for immediate ordering.
To learn more about hACE2 mice or Taconic's Coronavirus Toolkit, please contact Taconic at 1–888–TACONIC (888–822–6642) in the US, +45 70 23 04 05 in Europe, or email info@taconic.com.
About Taconic Biosciences, Inc.
Taconic Biosciences is a fully–licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno–oncology mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia, and has global shipping capabilities to provide animal models almost anywhere in the world.
Media Contact: Kelly Owen Grover
Director of Marketing Communications
(518) 697–3824
kelly.grover@taconic.com
GLOBENEWSWIRE (Distribution ID 8225107)
HAMBURG, Germany, April 28, 2021 (GLOBE NEWSWIRE) — The following is a GSB statement, on the non–existent Osint Group and the doubts about Karatbars' existing gold and the V999 fraud in connection with Rainer von Holst.
If fraud and abuse of title (also called imposture) knows no bounds due to a lack of awareness of injustice, then one can call oneself a US lawyer and US notary public in hiding and living illegally in the United States of America (USA), as Rainer von Holst alias Jan Faber or Dr. Peter Klein, among others, demonstrably did recently in an e–mail to a news agency in the Federal Republic of Germany.
It is a fact that the allegedly gold–backed V999 Coin cannot have an “auditor” with the name “Osint Group”, as Harald Seiz and E–Karat International claim in their white paper (https://v999.gold//documents/v999–platform–white–paper.pdf) and to various investors, since this company does not even exist, but the Osint Group has merely sprung from the questionable imagination of Rainer von Holst, who put an “Osint Group” logo and a https://osint.group construction kit website on the internet for this purpose.
In this context, the affiliates who deal with the allegedly gold–backed V999 Coin and actively advertise for it have to face the question of complicity, here in relation to the responsibility towards the gold investors, with regard to demonstrably ongoing investigations by the public prosecutor's office against Rainer von Holst and his network.
That the Karatbars boss Harald Seiz has lured his investors directly to the V999 platform of the allegedly gold–backed V999 Coin with the BUV, UNV and QR gold codes, whereby the non–existence of gold auditors (Osint Group) has been proven, are facts. The reality is also that Karatbars investor gold accounts have been linked to those of the V999 Coin, as can be seen on YouTube and various affiliates advertise how to link Karatbars accounts to the V999 platform with just one click.
Source: https://www.youtube.com/watch?app=desktop&v=iYOK1L2CSj0
Moreover, investors have been waiting for 2 (two) years for the gold invested as well as purchased and already saved by investors, which is why there are countless complaints to authorities from investors who call it an international fraud, as one hears more and more often.
Already the renowned German business newspaper “Handelsblatt” reported in June 2020, under the title: “The public prosecutor doubts the gold reserves of the Karatbars Group”, about the massive doubts regarding the possible non–existent gold.
Source: https://www.handelsblatt.com/finanzen/maerkte/devisen–rohstoffe/dubioser–goldhaendler–die–staatsanwaltschaft–zweifelt–an–den–goldreserven–der–karatbars–gruppe/25945106.html
In this round dance, Jakob B. appears, who returns in the chat of https://t.me/karatbarslawsuit, whereby von Holst has been claiming for some time that he has bought journalists, which is currently the subject of investigations by the public prosecutor's office.
Chris Saunders is described by Rainer von Holst as a “criminal” and a “stupid talker”, whom Jakob B. is currently suing, according to a statement made by Rainer von Holst to media representatives. This is surprising, because it was Chris Saunders in the USA who recently stated in a video that he had an engagement (assignment) from Jakob B. and a renowned German business newspaper.
Source: https://facebook.com/24karatchris/videos/177054424240274
As Rainer von Holst's scam has been known for a long time, the internationally renowned Stiftung Warentest already reported on the impostor and blackmailer in 2018.
Source: https://www.test.de/Rainer–von–Holst–Warum–wird–Anlagehai–nicht–ausgeliefert–5594662–0
In his obvious delusions of grandeur as a fraudster, blackmailer and impostor, Rainer von Holst forgot that in this day and age it does not take very long to find out whether a person is really a notary and lawyer, for which it is moreover absolutely necessary that the person has US citizenship, as the US Embassy in London has informed us factually – which exposes the baseless lies of Rainer von Holst and his network.
Here every person can check that Rainer von Holst, contrary to his insane claims, is not a notary and also not a lawyer and there is also no Dr. Peter Klein in the USA as a lawyer, which is why it is clear that Rainer von Holst alias Jan Faber, who also calls himself Dr. Peter Klein, is an internationally wanted fraudster, impostor and internet blackmailer, who has been acting as a blackmailer on the internet for many years with lies and slander of “gerlachreport” https://www.gerlachreport.com.
1)
https://www.notarypublicstamps.com/find–a–notary
2)
https://www.nationalnotary.org
4)
https://www.hg.org/usacities.asp
Moreover, in the United States of America, a notary is a person appointed by the government of a state, for example by the governor and the lieutenant governor, but what US governor would allow himself to be photographed with a Rainer von Holst or even appoint an internationally wanted fraudster like Rainer von Holst as US notary?
The fact that Rainer von Holst demands from a German news agency, without any sense of injustice, that it refrain from disseminating reports about him, here in obviously boundless self–conceit, whereby he sounds full of pomposity that the renowned German newspaper “Kyffhuser Nachrichten” had lost a lawsuit and would thus have to delete publications about him, is another brazen Rainer von Holst lie.
The “Kyffhuser Nachrichten” is above reproach and is published in association with other media, such as: nnz–online.de, eichsfelder–nachrichten.de, msh–online.de, uhz–online.de, nordthueringen.de, nnz–tv.de, among others. The untrue statements made by Rainer von Holst to a news agency can once again be debunked within seconds, as the web link proves.
Source: https://www.kyffhaeuser–nachrichten.de/news/news_lang_druck.php?ArtNr=230553
As in many of his activities, Rainer von Holst is obviously relying on people being impressed by his baseless e–mail gibberish in the letters he writes. These times, however, are over, everything that comes from this person is currently being checked, the agencies and the media are informed about the actions of the internationally wanted fraudster, con man and internet blackmailer, Rainer von Holst. Where von Holst insists on data protection, he will be happy to enforce it when Rainer von Holst is arrested in the USA, extradited and stands trial.
The US embassies have been informed about the current press articles on Rainer von Holst and the non–existent Osint Group and, after receiving feedback, have commissioned investigations by the FBI (Federal Bureau of Investigation) in the USA.
It thus remains to be seen when Rainer von Holst, who has gone into hiding, will be arrested and stand trial together with his criminal network, with Article 6(2) of the ECHR applying.
META KEYS:
V999, Rainer von Holst, Jan Faber, Harald Seiz, Dr. Peter Klein, Peter Klein, Karatbars, Federal Bureau of Investigation, FBI, Osint Group, Jakob B., Chris Saunders, Whitepaper V999, BUV, UNV
Legally responsible for this press release:
GSB Gold Standard Banking Corporation AG
Grosse Bleichen 35
D–20354 Hamburg
Register of the Hamburg Local Court, No: HRB 161409
Federal Republic of Germany
Press Department:
Mrs. Berger
Phone: +49 40 376 69 19 – 0
Fax: +49 40 376 69 89 – 3
Mail: Media@GSB.gold
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1d692296–8b08–4f61–97e3–27c0f70600d3
GLOBENEWSWIRE (Distribution ID 8225801)
QUEBEC CITY, April 28, 2021 (GLOBE NEWSWIRE) — LeddarTech , a global leader in Level 1–5 ADAS and AD sensing technology, launches Leddar Sight, a robust, cost–effective 2D solid–state LiDAR sensor. This LiDAR is housed in a weatherproof enclosure. It uses flash illumination to deliver continuous, accurate detection and range of objects and obstacles in its entire field of view, without any moving parts. Leddar Sight has been developed to answer the stringent needs of mobility, ITS, and industrial system developers for reliable, durable LiDAR sensing in the most challenging environments.
Unmatched Robustness for the Most Demanding Environments
Based on the Leddar M16 2D flash LiDAR module family's field–proven reliability, the Leddar Sight leverages a 100% solid–state design for ultimate robustness. Tested for shock and vibration to meet the most demanding commercial and industrial applications requirements, Leddar Sight features a weatherproof casing (IP67/IP69 rated) that resists dust ingress, immersion, and pressurized water streams.
Accelerated Path to Commercial Deployment
The Leddar Sight 2D flash LiDAR provides precise detection and measurement capabilities for indoor applications such as industrial automation and various outdoor applications such as autonomous navigation, obstacle detection, collision avoidance, precision maneuvering, speed enforcement, and automated tolling. Thanks to its robust enclosure, M12 connector, and various FoV options, the sensor can be rapidly integrated into prototypes and used to collect field data for software development and is available in volume today to customers, system integrators, and resellers for commercial deployments.
The Leddar Sight is an ideal LiDAR solution for shuttles, robotaxis, ADVs, commercial trucks, buses, industrial vehicles, mobile robotics, and intelligent transportation systems.
Leddar Sight 2D Solid–State LiDAR Key Features
"This new offering in our 2D flash LiDAR portfolio addresses a critical need expressed by our customers for a reliable, affordable LiDAR sensor that can operate in challenging conditions where shocks, vibrations, water and dust ingress, and wide operating temperature ranges are key concerns," said Daniel Aitken, Vice President of Global Marketing, Communications, and Product Management from LeddarTech. "Unlike mechanical LiDARs, Leddar Sight uses a proven solid–state flash design which delivers much longer inherent MTBF, and its robust casing makes it field–ready for 24/7 operation in the harshest commercial and industrial settings."
About LeddarTech
LeddarTech is a leader in environmental sensing platforms for autonomous vehicles and advanced driver assistance systems. Founded in 2007, LeddarTech has evolved to become a comprehensive end–to–end environmental sensing company by enabling customers to solve critical sensing and perception challenges across the entire value chain of the automotive and mobility market segments. With its LeddarVision sensor–fusion and perception platform and its cost–effective, scalable, and versatile LiDAR development solution for automotive–grade solid–state LiDARs based on the LeddarEngine, LeddarTech enables Tier 1–2 automotive system integrators to develop full–stack sensing solutions for autonomy level 1 to 5. These solutions are actively deployed in autonomous shuttles, trucks, buses, delivery vehicles, smart cities/factories, and robotaxi applications. The company is responsible for several innovations in cutting–edge automotive and mobility remote–sensing applications, with over 95 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.
Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook, and YouTube.
Contact:
Daniel Aitken, Vice–President, Global Marketing, Communications, and Product Management, LeddarTech Inc.
Tel.: + 1–418–653–9000 ext. 232
daniel.aitken@leddartech.com
Leddar, LeddarTech, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, VAYADrive, VayaVision, and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names, and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/645d13a2–1348–4cb0–bdea–21f4668ce468
GLOBENEWSWIRE (Distribution ID 8223740)
NEW YORK, April 27, 2021 (GLOBE NEWSWIRE) — JobDiva is proud to announce an integration with Jobs on Facebook""one of the first integrations of its kind.
Jobs on Facebook makes it simple for employers and recruiters to post jobs, manage applications and communicate with candidates more easily. By synchronizing job openings, JobDiva's integration with Jobs on Facebook empowers businesses to reach candidates where they are spending significant amounts of time.
"At JobDiva, we are focused on reducing unemployment during these uncertain times, as well as matching the workforce with their desired opportunities by maximizing our clients' capabilities""and doing so quickly, in the interest of the public at large," said Gus Samra, JobDiva's Chief Revenue Officer. "JobDiva's integration with Jobs on Facebook is a signal example of our commitment to talent and client success, and we're ecstatic to offer this integration."
About JobDiva: JobDiva, the leading global ATS, is delivered to clients via the cloud. JobDiva stands as the top–tier ATS, defining the path of innovation in staffing technology.
Contact:
Bella Chen
Head of Marketing, JobDiva
Bella.chen@jobdiva.com
+1 212–384–6566
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/65890c74–c25d–4a3c–a1a1–b11802201711
GLOBENEWSWIRE (Distribution ID 8223999)
MUNICH and NEW YORK, April 27, 2021 (GLOBE NEWSWIRE) — For the past ten years, the United Nations Alliance of Civilizations (UNAOC) and the BMW Group have invited organisations around the world to apply for the Intercultural Innovation Award. The two partners have used this award to support innovative projects promoting intercultural understanding.
"As we celebrate ten years of this ever–growing partnership between UNAOC and the BMW Group and now with the support of Accenture, we shall continue to collaborate to amplify the work of cutting–edge social innovators and promote diversity and inclusive societies," said Mr. Miguel ngel Moratinos, High Representative for UNAOC.
"In our anniversary year, we are not only celebrating a very successful partnership, but also using the Intercultural Innovation Award once again to appeal to people's feeling of community," said Ilka Horstmeier, member of the Board of Management of BMW AG responsible for Human Resources and new patron of the Intercultural Innovation Award. This takes on a whole new meaning in the face of Covid–19. As Horstmeier said, "We can only manage the added challenges of the pandemic by taking action together."
Wanted: projects for an inclusive and diverse society
This year, the focus will primarily be on projects promoting gender equality, countering violent extremism, hatred, and prejudices and advocating for art, culture, and sports as vehicles for social cohesion and diversity.
To leverage the social impact of the selected projects, all ten finalists will receive the same financial assistance. For this reason, with the support of Accenture, the partners have increased the financial award to USD 200,000. In addition, the finalists will receive individual and professional consulting and participate in various training sessions and workshops.
Interested organisations shall submit their application by 5:00 p.m. (EDT) on Thursday, 27 May 2021, at www.interculturalinnovation.org.
Contact:
Milena Pighi, BMW Group Corporate and Governmental Affairs, Spokesperson CSR
Contact +49–89–382–66563; Milena.PA.Pighi@bmw.de
https://www.bmwgroup.com
Alessandro Girola, Programming Coordinator, UNAOC
Contact: +1 (929) 274–6217; alessandrog@unops.org
https://www.unaoc.org
GLOBENEWSWIRE (Distribution ID 8224541)
BRISBANE, Australia, April 27, 2021 (GLOBE NEWSWIRE) — Analytica Limited (ASX:ALT), the Australian developer of the Enhanced Infusion System (EIS) and PeriCoach pelvic floor exercise system for the treatment of stress urinary incontinence, has entered into an agreement with Marwa's Office for Export & Import Medical Supplies (Marwa) to distribute, market and sell the EIS to hospital systems in Egypt, Bahrain, Iran, Iraq, Jordan, Kuwait, Lebanon, Saudi Arabia and United Arab Emirates.
The EIS technology was developed by Analytica under the project names AutoStart and AutoFlush and has been sold in Australia with the trade name FirstFlow, under limited license. EIS combines the AutoStart and AutoFlush patented technologies into a simple and inexpensive solution.
The patented float system automatically restarts IV fluid flow following medication delivery, thereby saving healthcare workers' time, reducing hospital costs and preventing the adverse events associated with air embolism and failure of Peripheral Intravenous Catheters (PIVC). The EIS reacts immediately, silently and without intervention or programming. It can be retrofitted to any existing infusion system design and can work in harmony with and improve the capability of any infusion pump or "bag' infusion system, regardless of sophistication.
Use of the EIS uniquely allows a completely closed infusion system, with integrity achieved by reducing the interactions believed to cause mechanical and vascular complications as well as good flushing and/or patency practice.
The EIS has an Australian TGA ARTG registration and USFDA 510(k) clearance. It is fully compliant with ISO 8536 infusion system and other relevant standards.
The EIS can markedly reduce legal risks by addressing multiple factors that can impact patients, clinicians and hospitals, including:
Given the health and legal risk–reduction features of the EIS, the home–based hospital care market represents a growth opportunity globally. The EIS is compact, rugged and does not require a pump or energy source, which makes it suitable for retrieval, military and third world needs without compromising risk.
To view a video about the operation and features of the EIS, please click here.
Marwa's Principal has extensive experience with the Egyptian health system, as a consultant and undersecretary of health for the Egyptian Health Insurance Organization Clinics (HIO) as well as leadership positions in the Egyptian Ministry of Health.
"Marwa has presented a compelling opportunity with experienced professionals to take Analytica's Enhanced Infusion System (EIS) into a large and growing market in the Middle East," said Dr. Michael Monsour, Chairman of Analytica Ltd. "We look forward to working with Marwa to expand the usage of our unique EIS technology."
For more information about Analytica and the Enhanced Infusion System, visit www.AnalyticaMedical.com
For investor or business inquiries, please contact: investorrelations@analyticamedical.com
For media inquiries, please contact: Annie Starr, astarr@6degreespr.com
About Analytica Limited
Analytica is a product development and commercialisation company based in Brisbane, Australia that is focussed on Class I and II medical device products.
Analytica is the developer of the Enhanced Infusion System (EIS), a combination of patented technologies developed under the project names AutoStart and AutoFlush. The EIS is a simple and inexpensive IV add–in technology to decrease nursing monitoring costs, reduce embolism risk, improve infection control, and automatically restart flow after medication delivery during intravenous fluid infusion.
Analytica is also the manufacturer of the PeriCoach System, an e–health treatment system for women who suffer stress urinary incontinence. This affects 1 in 3 women worldwide and is mostly caused by trauma to the pelvic floor muscles because of pregnancy, childbirth and menopause.
____________________
Trademark of ICU Medical Australia.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d7af8a18–4b05–4cae–a8bb–71d578ab84fc
GLOBENEWSWIRE (Distribution ID 8224474)
NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) — Bitwats is now quickly emerging as the next big name in the world of crypto mining. The company's three multi–algorithm miners BT, DBT, and GBT have already carved a niche in the market because of their ability to generate 100% return on investment within just one month. Another key attribute of these miners is their ease of operation.
The extraordinary profitability of the ASIC miners from Bitwats is because of their extremely high hash rates, which refers to the total combined computational power used to mine and process transactions on a Proof–of–Work blockchain. The three miners can be used for mining bitcoin, litecoin, ethereum, and monero with the hash rates as mentioned below.
| BTC (TH/s) | LTC (GH/s) | ETH (GH/s) | XMR (MH/s) | |
| BT | 360 | 60 | 3 | 3 |
| DBT | 750 | 130 | 7 | 7 |
| GBT | 2250 | 390 | 21 | 21 |
Based on figures mentioned above, monthly profit making potential of DBT and CBT units are summarized below.
While designing its crypto miners, Bitwats wanted to deliver products that can be used easily by all, including the small time crypto enthusiasts with little or no mining knowledge or experience. The products are delivered pre–configured, and customers just need to plug in and start making profits. To provide additional savings for its customers, Bitwats also offers its own mining pool with 0% fees for them.
Bitwats delivers all its products across the globe except countries in war zone, with a guaranteed delivery time of just 7 days. The company covers the delivery and custom fees for its customers. All buyers also receive 2 years product warranty and 30 days money back guarantee.
"Lack of crypto mining knowledge or experience is no longer an obstacle to your aspirations as a mining enthusiast. Welcome to the world of Bitwats, an advanced line of ASIC miners created specifically for the newbies looking to make a guaranteed profit from crypto mining. Our plug–and–play mining hardware makes life easier not only for beginners but also for mining experts looking to scale their profit," said Mark Williams CEO of Bitwats.
To find out more, please visit https://bitwats.com/
About Bitwats: Bitwats was founded in 2016 by a team of technology leaders with a track record of working for the world's most prodigious companies in the past. Dedicated to bringing the latest crypto–mining technology to the public, the company has recently introduced its exquisite line of advanced ASIC miners. Unlike most other crypto mining hardware manufacturers, Bitwats continuously works towards making crypto mining easy and profitable for all regardless of their experience and knowledge.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/87cad474–83a4–4441–a81f–0f52c1149a0f
GLOBENEWSWIRE (Distribution ID 8223736)